Delicpol acquired Cuprod
Our portfolio company, Delicpol, is consolidating the Polish confectionery market by acquiring 100% of the shares ofCuprod, a Polish manufacturer from Kluczborg. The transaction was financed by us and by AXA Private Equity.
The acquisition of Cuprod is the next step in our strategy to build one of Europe’s major confectionery producers. Tomasz Grzybowski, the CEO of Delicpol, will manage the Group. Cuprod's founders and management team will remain in the Group.
"Consolidation of fragmented markets is an important part of our strategy. We don't exclude further M&As in Poland an in the region," said Ryszard Wojtkowski.
"Thanks to this transaction our production capacity increased, as well as the ability to diversify our product portfolio. It will allow us to better address customers' needs and to increase our presence on the market," said Tomasz Grzybowski, Delicpol's CEO.
"The merger with the market leader will help us fully utilize our production capacities createdin recent years and open the company to new challenges," added Krzysztof Kozłowski, CEO of Cuprod.
The LUX MED Group has acquired CM MAVIT Sp. z o.o., which includes an ophthalmological hospital and diagnostic center in Warsaw and a specialist hospital in Katowice, offering medical services in the field of ophthalmology, maxillo-facial surgery and ENT. This is one of the largest transactions of this type on the Polish healthcare market in recent years.
The company known for box-based diets, is becoming a market consolidator. As for now, it has built up space for almost threefold increase in sales.